- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Senores Pharmaceuticals
Market Cap: ₹23.8b
Develops, manufactures, and sells, pharmaceutical products in India, the United States, Canada, and internationally.
SENORES
₹517.05
7D
-5.9%
1Y
n/a
Solara Active Pharma Sciences
Market Cap: ₹24.5b
Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
SOLARA
₹508.85
7D
-2.8%
1Y
-6.2%
Strides Pharma Science
Market Cap: ₹60.2b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.
STAR
₹653.45
7D
0.07%
1Y
-25.5%